Contact allergy to isopropanolamine in Traxam® gel

Contact Dermatitis

Volumn 41, Issue 4, 1999, Pages 233-234

  Cooper, S M ^a   Shaw, S ^a  

^a AMERSHAM HOSPITAL   (United Kingdom)

Author keywords

Allergic contact dermatitis; Isopropanolamine; Medicaments; Non steroidal anti inflammatories; Traxam gel

Indexed keywords

FELBINAC; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LEG ULCER; OSTEOARTHRITIS; PATCH TEST; SKIN ALLERGY; TOPICAL DRUG ADMINISTRATION;

EID: 0032887876     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0536.1999.tb06147.x     Document Type: Article

References (3)

1. Final report on the salary assessment of diisopropanolamine, triisopropanolamine, isopropanolamine, and mixed isopropanolamine. Journal of the American College of Toxicology 1987: 6: 53-76.
2. Ophaswongse S, Maibach H. Topical non-steroidal anti-inflammatory drugs: allergic and photoallergic contact dermatitis and phototoxicity. Contact Dermatitis 1993: 29: 57-64.
3. Kranke B, Szolar-Platzer C, Komericki P, Derhaschnig J, Aberer W. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer. Contact Dermatitis 1997: 36: 212-215.